The European Association for Osseointegration (EAO) consistently seeks to advance dental practice through evidence-based research. One of their key initiatives is the biennial consensus conference, which brings together international experts to discuss and consolidate the latest findings. This article summarises the essential insights from the recent conference on the topic of drugs and diseases, highlighting practical implications for clinicians.
The Role of Consensus Conferences The primary goal of EAO's consensus conferences is to translate complex scientific research into actionable guidelines for clinical practice. These conferences result in comprehensive reports, such as the 300-page proceedings document. Recognising that busy practitioners may not have the time to delve into such extensive materials, the EAO also provides a digest of the key points, which is available in multiple languages for broader accessibility.
Focus on Drugs and Diseases In the latest consensus conference, one of the groups focused on the impact of various drugs and diseases on dental health. Dr. Luis Sanchez from Alicante, Spain, was part of this group and shared insights on three main topics: platelet concentrates, titanium particles, and antiresorptive drugs.
1. Platelet Concentrates:
Current Understanding:
The use of platelet concentrates in dental procedures, such as sinus lifts, does not show significant differences compared to traditional techniques. Importantly, there is no evidence of negative effects from using platelet concentrates. Clinical Implication:
Dentists can use platelet concentrates without fear of adverse effects, but should not expect superior outcomes compared to conventional methods. 2. Titanium Particles:
Bio-Corrosion and Allergies:
Concerns about allergies to titanium particles exist, but cases are extremely rare. Tests such as patch tests and lymphocyte transformation tests are unreliable and prone to false positives. Peri-Implantitis:
The role of titanium particles in peri-implantitis remains unclear. Various sources, including micro-motion during implant placement and components in oral hygiene products, contribute to the presence of titanium particles in tissues. Clinical Implication:
While the risk of allergy to titanium is low, clinicians should be aware of its potential, particularly in patients showing symptoms. Current diagnostic tests for titanium allergies are not recommended due to their inaccuracy. 3. Antiresorptive Drugs:
Risks and Monitoring:
Antiresorptive drugs, used to treat conditions like osteoporosis, can cause medication-related osteonecrosis of the jaw (MRONJ). The risk increases significantly if the patient has been on these medications for over 36 months. Clinical Implication:
It is crucial for dental practitioners to include a thorough review of a patient's medication history during the intake process, specifically noting the duration of antiresorptive drug use. Awareness and monitoring of these factors can help mitigate the risk of MRONJ. Practical Recommendations From the findings of the EAO consensus conference, several practical recommendations emerge for clinicians:
Integrate Evidence-Based Practices:
Utilize platelet concentrates with confidence in their safety but manage expectations regarding their efficacy compared to traditional methods. Assess Allergies with Caution:
Be cautious with titanium allergy tests, and consider the clinical context and symptoms before concluding a diagnosis. Monitor Medication Histories:
Implement detailed patient intake procedures to track the use of antiresorptive drugs and assess the associated risks of MRONJ. Conclusion The EAO consensus conference provides invaluable insights that bridge the gap between scientific research and clinical practice. By adopting these guidelines, dental professionals can enhance patient care and stay at the forefront of dental health advancements. For more detailed information, clinicians are encouraged to visit the EAO website and access the full digest of the conference findings, available in multiple languages.
Staying informed and proactive in integrating new research into clinical practice is essential for delivering the best patient outcomes in the dynamic field of dental medicine.